Cargando…

Risk Factors of Cytomegalovirus Reactivation in Ulcerative Colitis Patients: A Meta-Analysis

Cytomegalovirus (CMV) infection is associated with exacerbation of disease activity in patients with ulcerative colitis (UC). However, the risk factors for CMV reactivation in this population remain debatable. This meta-analysis was performed to identify the risk factors for CMV reactivation in UC p...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Yafei, Wang, Grace, Kong, Dejun, Li, Guangming, Wang, Hongda, Qin, Hong, Wang, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625464/
https://www.ncbi.nlm.nih.gov/pubmed/34829298
http://dx.doi.org/10.3390/diagnostics11111952
_version_ 1784606427925446656
author Qin, Yafei
Wang, Grace
Kong, Dejun
Li, Guangming
Wang, Hongda
Qin, Hong
Wang, Hao
author_facet Qin, Yafei
Wang, Grace
Kong, Dejun
Li, Guangming
Wang, Hongda
Qin, Hong
Wang, Hao
author_sort Qin, Yafei
collection PubMed
description Cytomegalovirus (CMV) infection is associated with exacerbation of disease activity in patients with ulcerative colitis (UC). However, the risk factors for CMV reactivation in this population remain debatable. This meta-analysis was performed to identify the risk factors for CMV reactivation in UC patients. PubMed, Cochrane Library, EMBASE, Web of Science, and China National Knowledge Infrastructure were searched from the inception of these databases to 31 August 2021, with the aim of identifying studies that investigated the risk factors of CMV reactivation in UC patients. A quality assessment of the included studies was performed with the Newcastle-Ottawa Scale. The publication bias was assessed respectively via a funnel plot and Egger’s regression asymmetry test. The robustness and reliability of each outcome were evaluated by sensitivity analysis. Twenty studies were included in the final meta-analysis, comprising a total of 2099 patients with UC. A significantly higher risk of CMV reactivation was observed in patients with severe UC (OR = 1.465, 95% CI: 1.107 to 1.939, p = 0.008), pancolitis (OR = 2.108, 95% CI: 1.586 to 2.800, p = 0.0001), older age of UC onset (MD = 6.212, 95% CI: 2.552 to 9.971, p = 0.001), as well as use of glucocorticoids (OR = 4.175, 95% CI: 3.076 to 5.666, p = 0.001), immunosuppressants (OR = 1.795, 95% CI: 1.289 to 2.501, p = 0.001), and azathioprine (OR = 1.444, 95% CI: 1.012 to 2.061, p = 0.043). However, infliximab treatment was observed not to increase the occurrence of CMV reactivation in patients who suffered from UC. In contrast, 5-aminosalicylic acid (OR = 0.674, 95% CI: 0.492 to 0.924, p = 0.014) was associated with a lower risk of CMV reactivation. Patients with UC should be closely monitored for risk factors of CMV reactivation in order to provide timely diagnosis and antiviral treatment.
format Online
Article
Text
id pubmed-8625464
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86254642021-11-27 Risk Factors of Cytomegalovirus Reactivation in Ulcerative Colitis Patients: A Meta-Analysis Qin, Yafei Wang, Grace Kong, Dejun Li, Guangming Wang, Hongda Qin, Hong Wang, Hao Diagnostics (Basel) Review Cytomegalovirus (CMV) infection is associated with exacerbation of disease activity in patients with ulcerative colitis (UC). However, the risk factors for CMV reactivation in this population remain debatable. This meta-analysis was performed to identify the risk factors for CMV reactivation in UC patients. PubMed, Cochrane Library, EMBASE, Web of Science, and China National Knowledge Infrastructure were searched from the inception of these databases to 31 August 2021, with the aim of identifying studies that investigated the risk factors of CMV reactivation in UC patients. A quality assessment of the included studies was performed with the Newcastle-Ottawa Scale. The publication bias was assessed respectively via a funnel plot and Egger’s regression asymmetry test. The robustness and reliability of each outcome were evaluated by sensitivity analysis. Twenty studies were included in the final meta-analysis, comprising a total of 2099 patients with UC. A significantly higher risk of CMV reactivation was observed in patients with severe UC (OR = 1.465, 95% CI: 1.107 to 1.939, p = 0.008), pancolitis (OR = 2.108, 95% CI: 1.586 to 2.800, p = 0.0001), older age of UC onset (MD = 6.212, 95% CI: 2.552 to 9.971, p = 0.001), as well as use of glucocorticoids (OR = 4.175, 95% CI: 3.076 to 5.666, p = 0.001), immunosuppressants (OR = 1.795, 95% CI: 1.289 to 2.501, p = 0.001), and azathioprine (OR = 1.444, 95% CI: 1.012 to 2.061, p = 0.043). However, infliximab treatment was observed not to increase the occurrence of CMV reactivation in patients who suffered from UC. In contrast, 5-aminosalicylic acid (OR = 0.674, 95% CI: 0.492 to 0.924, p = 0.014) was associated with a lower risk of CMV reactivation. Patients with UC should be closely monitored for risk factors of CMV reactivation in order to provide timely diagnosis and antiviral treatment. MDPI 2021-10-21 /pmc/articles/PMC8625464/ /pubmed/34829298 http://dx.doi.org/10.3390/diagnostics11111952 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Qin, Yafei
Wang, Grace
Kong, Dejun
Li, Guangming
Wang, Hongda
Qin, Hong
Wang, Hao
Risk Factors of Cytomegalovirus Reactivation in Ulcerative Colitis Patients: A Meta-Analysis
title Risk Factors of Cytomegalovirus Reactivation in Ulcerative Colitis Patients: A Meta-Analysis
title_full Risk Factors of Cytomegalovirus Reactivation in Ulcerative Colitis Patients: A Meta-Analysis
title_fullStr Risk Factors of Cytomegalovirus Reactivation in Ulcerative Colitis Patients: A Meta-Analysis
title_full_unstemmed Risk Factors of Cytomegalovirus Reactivation in Ulcerative Colitis Patients: A Meta-Analysis
title_short Risk Factors of Cytomegalovirus Reactivation in Ulcerative Colitis Patients: A Meta-Analysis
title_sort risk factors of cytomegalovirus reactivation in ulcerative colitis patients: a meta-analysis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625464/
https://www.ncbi.nlm.nih.gov/pubmed/34829298
http://dx.doi.org/10.3390/diagnostics11111952
work_keys_str_mv AT qinyafei riskfactorsofcytomegalovirusreactivationinulcerativecolitispatientsametaanalysis
AT wanggrace riskfactorsofcytomegalovirusreactivationinulcerativecolitispatientsametaanalysis
AT kongdejun riskfactorsofcytomegalovirusreactivationinulcerativecolitispatientsametaanalysis
AT liguangming riskfactorsofcytomegalovirusreactivationinulcerativecolitispatientsametaanalysis
AT wanghongda riskfactorsofcytomegalovirusreactivationinulcerativecolitispatientsametaanalysis
AT qinhong riskfactorsofcytomegalovirusreactivationinulcerativecolitispatientsametaanalysis
AT wanghao riskfactorsofcytomegalovirusreactivationinulcerativecolitispatientsametaanalysis